Global Health Limited Reports Robust Q2 FY27 Financial Results
Global Health Ltd 路 Investor Presentation 路 14 Nov 2026, 6:23 pm
Global Health Limited Reports Robust Q2 FY27 Financial Results Global Health delivered strong Q2 FY27 operational growth, with revenue from operations rising 33.6% YoY to INR 14,690 mn and operating EBITDA jumping 60.2% YoY to INR 3,701 mn, expanding margins 418 bps YoY to 25.2%. PAT increased 38.3% YoY to INR 2,191 mn. Growth was driven by IPD and OPD volume surges of 29.5% and 37.9% YoY, respectively, alongside 22.4% YoY growth in occupied bed days. Noida operations achieved EBITDA breakeven at INR 86 mn. Medanta planned a capex of ~INR 62,390 mn.
Original exchange filing (PDF)
More announcements from Global Health Ltd
- Intimation of Credit Rating by Crisil. 路 18 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 18 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 16 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under Regulation 30 of SEBI Listing Regulations, 2015 for Earning Conference Call Transcript. 路 10 Nov 2026
